Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471867) titled 'Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRvention' on March 4.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: Yonsei University
Condition:
Chronic Coronary Syndrome
Intervention:
Drug: Zastaprazan
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: March 17, 2026
Target Sample Size: 100
Countries of Recruitment:
South Korea
To know more, visit https://clinicaltrials...